SCHEMBL10537641

SCHEMBL10537641

O=C1CC(c2ccc(Cl)cc2)Sc2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 6/20 0.51
SMN1; SMN2 Q16637 5/20 0.47
LMNA P02545 4/20 0.47
NPSR1 Q6W5P4 3/20 0.47
KDM4E B2RXH2 2/20 0.47
HTT P42858 2/20 0.47
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
RAB9A P51151 1/20 0.46
ALDH1A1 P00352 3/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45
ACHE P22303 2/20 0.42
BCHE P06276 2/20 0.42
MAPT P10636 3/20 0.42
MAPK1 P28482 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8817667 0.88 SMN1; SMN2 (0.56) GSK3BSMN1; SMN2LMNAKDM4ECRHBP
SCHEMBL10537698 0.86 VHL (0.47) GSK3BSMN1; SMN2LMNANPSR1KDM4E
SCHEMBL10534782 0.83 HPGD (0.49) GSK3BSMN1; SMN2LMNANPSR1KDM4E
SCHEMBL21982716 0.72 SIGMAR1 (0.41) GSK3BSMN1; SMN2KDM4ECRHBPCRHR2
SCHEMBL11374339 0.71 POLB (0.47) GSK3BSMN1; SMN2LMNANPSR1KDM4E
SCHEMBL68859 0.70 ALDH1A1 (0.57) GSK3BSMN1; SMN2KDM4EHTTPOLB
SCHEMBL10814919 0.70 SIGMAR1 (0.47) GSK3BSMN1; SMN2KDM4EUSP2POLB
SCHEMBL8373688 0.70 SIGMAR1 (0.43) GSK3BSMN1; SMN2LMNAKDM4EHTT
SCHEMBL28814207 0.70 SIGMAR1 (0.43) GSK3BSMN1; SMN2LMNAKDM4EALDH1A1
SCHEMBL6001645 0.70 RAB9A (0.49) SMN1; SMN2LMNANPSR1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4801593-A VIRICIDE FOR RHINITIS VIRUS CONTAINING 2-PHENYLTETRALIN DERIVATIVE BURROUGHS WELLCOME CO. (US) 1989-01-31 US disclosed
EP-0025598-B1 THE USE OF 2-PHENYLTETRALIN DERIVATIVES, OR HETEROCYCLIC ANALOGUES, IN MEDICINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM THE WELLCOME FOUNDATION LIMITED (GB) 1984-08-01 EP disclosed
EP-0025598-A1 The use of 2-phenyltetralin derivatives, or heterocyclic analogues, in medicine and pharmaceutical compositions containing them THE WELLCOME FOUNDATION LIMITED (GB) 1981-03-25 EP disclosed